Back to School: How biopharma can reboot drug development. Access exclusive analysis here
ABTI (Worcester, Mass.) announced results of its second Phase II study at the Surgical Infectious Society meeting in Toronto.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury